Conférences - Hématologie

International Academy for Clinical Hematology (IACH)

We are delighted to invite you to participate in the 2nd Annual Meeting of the International Academy for Clinical Hematology (IACH), taking place September 19-21, 2019 in Paris, France. The annual meeting of the IACH aims to create a comprehensive intellectual and operational environment for acquisition of knowledge, skills, clinical judgement, and attitudes essential for the practice of clinical hematology.

Email.: moran@cme-congresses.com

Hematology Immune System

Cancérologie,    Cellules souches

Euroasian Hematology Oncology Group

Dear Colleagues, We are pleased to announce that Xth Eurasian Hematology-Oncology Congress will be held between 8-11 October 2019 in Hilton İstanbul Bosphorus. We believe deep in our hearts that with its special concept, the International Eurasian Hematology-Oncology Congress will fill in a significant gap in our region and serve not only scientifically but also culturally. Looking forward to meeting with your respected selves between 8-11 October, we would like to extend our kindest regards.

Tél.: [+90 505 671 16 45];     Email.: Secretariat@hematology.org.tr

Tél.: [408-352-1010];     Email.: info@2019crtc.com

Cancer Biomarkers 2 Cancer Gene Therapy 3 Cancer Nursing 4 Clinical Oncology 5 Pediatric Oncology 6 Radiation, Surgical and Medical oncology 7 Cancer Genetics 8 Breast Cancer Research 9 Cancer Stem Cell Therapy 10 Innovations in prevention and screening 11 Anti-Cancer Drug Discovery & Therapy 12 Cancer Screening & Diagnosis 13 Cancer Immunology & Vaccines 14 Organ Specific Cancers and Effects

The 8th Conference of IAOC "Current Status and Future of Anti-Cancer Therapies" will be held in Buenos Aires, Argentina in October 17th and 18th, 2019. An outstanding faculty of speakers from the United States and Europe has committed in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development.

This meeting is the primary opportunity for oncologists, hematologists and cancer related health workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care.

Secretariat;     Email.: secretariat@oncologyconferences.com.ar

NEW ANTICANCER THERAPIES, MELANOMA, BREAST CANCER, GU CANCER, PROSTATE AND RENAL CANCER, BLADDER CANCER, GI CANCER, LUNG CANCER, HEMATOLOGICAL MALIGNANCIES, LYMPHOMA, LEUKEMIA, MULTIPLE MYELOMA

Since the inaugural Congress in 2001, this meeting has become the premier forum for discussion on the latest advances in myeloproliferative neoplasms (MPNs). This year, the Congress will focus on timely topics of interest to hematologists and oncologists who treat patients with these rare disorders. The Congress program format will utilize case presentations to highlight the essential features of MPN pathophysiology, diagnosis and management, as well as the roles of next generation sequencing and the MPN driver mutation and allele burden in clinical decision making. In addition to defining the role of pegylated interferon and its long-acting derivatives in MPN therapy, the role of immunotherapy in the MPNs and novel agents for MPN treatment will be reviewed. New this year will be a discussion of the management of accelerated and blast phase MPN, patient selection for bone marrow transplantation, and how to integrate MPN patient symptom scores with therapeutic planning. The program features a world class faculty and highly interactive sessions designed to engage participants and provide a state-of-the-art learning experience.

Tél.: [512-619-5534];     Email.: info@meltonmeded.com

myeloproliferative neoplasms, MPN, polycythemia vera, PV, essential thrombocythemia, ET, myelofibrosis, MF, PMF, Chronic myeloid leukemia, CML, CNL, mastocytosis, hematopoiesis

Cancérologie,    Formation médicale continue (FMC)

The 5th COSTEM Congress will be a progressive, compelling and informative conference. As per COSTEM’s crucial mission, the meeting will continue to serve as a distinct platform, where the most compelling and controversial topics facing clinicians in the field are presented in a fascinating and engaging debate forum. The congress promotes excellence through dynamic deliberation and leading-edge presentations by international experts. Aiming to integrate the sharing of expansive information with optimal implementation in clinical care, this state-of-the-art congress is unique in its focus on resolving controversies important to stem cell transplantation and cellular therapies.

Tél.: [+972528887612];     Email.: moran@cme-congresses.com

Der Hämato/Onko Refresher findet vom 08. - 09. November 2019 in Berlin statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Tél.: [+49 (0) 6192 957 89 41];     Email.: info@fomf.de

Hämatologie, Onkologie

Cancérologie,    Formation médicale continue (FMC)

Der Hämato/Onko Refresher findet vom 15. - 16. November 2019 in Stuttgart statt. In kurzen, 30 – 45 minütigen Vorträge werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Tél.: [+49 (0) 6192 957 89 41];     Email.: info@fomf.de

Hämatologie, Onkologie

Cancérologie,    Formation médicale continue (FMC)

This study day will explore aspects of contemporary haemato-oncology practice delivered by a variety of clinicians working within the specialty.

Conference Team;     Tél.: [02078082921];     Email.: conferenceteam@rmh.nhs.uk

Der Hämato/Onko Refresher findet vom 29. - 30. November 2019 in Köln statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Tél.: [+49 (0) 6192 957 89 41];     Email.: info@fomf.de

Hämatologie, Onkologie

Cancérologie,    Formation médicale continue (FMC)

Der DKK 2020 steht unter dem Motto informativ. innovativ. integrativ. Optimale Versorgung für alle.

Tél.: [+49 3643 2468-0];     Email.: info@kukm.de

Over the last few years, the myeloma field has made significant progresses. We have seen fascinating novel drugs being introduced (including innovative cellular therapies), and the whole treatment paradigm is progressively changing.

Like the previous ones, this international meeting aims to deliver state of the art science and research, focused on the latest advances in the field and on improving patient care.

The scientific content will be on the cutting-edge one because the pace of change in multiple myeloma is accelerating.

In addition to the science, you will be able to enjoy this most spectacular city of Paris. We are looking forward to seeing you in Paris next year

Tél.: [+972528887612];     Email.: moran@cme-congresses.com

Multiple Myeloma, cancer, CAR T Cell

Cancérologie,    Formation médicale continue (FMC)